Unexplained INR instability following switch from injectable to oral Semaglutide: a case report

Girard, Aurore
(2025) WONCA World Conference 2025 : New vision for primary health care and sustainable development — Location: (Portugal) Lisbon (17.September.2025)

Files

2025_Girard_WONCA_Semaglutide_Présentation.pdf
  • Open Access
  • Adobe PDF
  • 698.64 KB
Download
2025_Girard_WONCA_Semaglutide_Abstract.pdf
  • Open Access
  • Adobe PDF
  • 422.66 KB
Download

Details

Authors
Abstract
INTRODUCTION: Semaglutide, a GLP-1 receptor agonist used in type 2 diabetes, is available in both injectable and oral forms. While drug-drug interactions with vitamin K antagonists are uncommon, formulation changes may alter absorption and pharmacokinetics [...]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Girard, A. (2025). Unexplained INR instability following switch from injectable to oral Semaglutide: a case report. WONCA World Conference 2025 : New vision for primary health care and sustainable development, (Portugal) Lisbon. https://hdl.handle.net/2078.5/259490